1. Home
  2. RLMD vs FCAP Comparison

RLMD vs FCAP Comparison

Compare RLMD & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • FCAP
  • Stock Information
  • Founded
  • RLMD 2004
  • FCAP 1891
  • Country
  • RLMD United States
  • FCAP United States
  • Employees
  • RLMD N/A
  • FCAP N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • FCAP Savings Institutions
  • Sector
  • RLMD Health Care
  • FCAP Finance
  • Exchange
  • RLMD Nasdaq
  • FCAP Nasdaq
  • Market Cap
  • RLMD 110.6M
  • FCAP 114.3M
  • IPO Year
  • RLMD N/A
  • FCAP 1999
  • Fundamental
  • Price
  • RLMD $2.75
  • FCAP $32.47
  • Analyst Decision
  • RLMD Hold
  • FCAP
  • Analyst Count
  • RLMD 2
  • FCAP 0
  • Target Price
  • RLMD $7.50
  • FCAP N/A
  • AVG Volume (30 Days)
  • RLMD 126.6K
  • FCAP 2.0K
  • Earning Date
  • RLMD 11-07-2024
  • FCAP 10-25-2024
  • Dividend Yield
  • RLMD N/A
  • FCAP 3.48%
  • EPS Growth
  • RLMD N/A
  • FCAP N/A
  • EPS
  • RLMD N/A
  • FCAP 3.52
  • Revenue
  • RLMD N/A
  • FCAP $41,072,000.00
  • Revenue This Year
  • RLMD N/A
  • FCAP N/A
  • Revenue Next Year
  • RLMD N/A
  • FCAP N/A
  • P/E Ratio
  • RLMD N/A
  • FCAP $9.46
  • Revenue Growth
  • RLMD N/A
  • FCAP N/A
  • 52 Week Low
  • RLMD $1.88
  • FCAP $24.40
  • 52 Week High
  • RLMD $7.22
  • FCAP $38.00
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 23.58
  • FCAP 35.25
  • Support Level
  • RLMD $2.96
  • FCAP $33.00
  • Resistance Level
  • RLMD $3.43
  • FCAP $35.11
  • Average True Range (ATR)
  • RLMD 0.21
  • FCAP 0.37
  • MACD
  • RLMD -0.07
  • FCAP -0.28
  • Stochastic Oscillator
  • RLMD 1.60
  • FCAP 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About FCAP First Capital Inc.

First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.

Share on Social Networks: